InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Zygmont Chester Stanley III. Officer active across 1 company, notably Revelation Biosciences, INC.. Cumulatively, 8 disclosures have been published. History available since 11 February 2025. The latest transaction was disclosed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Zygmont Chester Stanley III is a declarant linked to Revelation Biosciences, INC. as Chief Financial Officer. The record shows 8 filings in total, and across the 8 sampled filings from 2025-02-13 to 2026-08-18, the reported buy and sell amounts are EUR 0 each, with transactions of Attribution nature.